Novo Nordisk | NVO - Market Capitalization

Stock Price
47.19
Daily Change
-3.06 -6.09%
Monthly
-14.45%
Yearly
-45.02%
Q1 Forecast
56.42

Novo Nordisk reported DKK160.71B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
ANI Pharmaceuticals USD 2.04B 630M Sep/2025
Aurora Cannabis CAD 470.14M 146.16M Sep/2025
Bausch Health Companies USD 2.38B 979.68M Sep/2025
Bristol-Myers Squibb USD 91.8B 2.4B Sep/2025
Canopy Growth CAD 136.67M 644.68M Feb/2026
Corcept Therapeutics USD 8.76B 977M Sep/2025
Drreddys Laboratories INR 2.28B 9.41B Feb/2026
Eli Lilly USD 1.02T 300.22B Feb/2026
GlaxoSmithKline GBP 86.59B 22.54B Feb/2026
Merck USD 293.38B 83.74B Feb/2026
Novartis USD 265.66B 9.48B Sep/2025
Novo Nordisk DKK 246.32B 60.06B Sep/2025
Novo Nordisk A/S DKK 1.54T 86.62B Feb/2026
Pacira USD 1.16B 51M Sep/2025
Perrigo USD 2.95B 698M Sep/2025
Prestige Brands USD 3.07B 860M Sep/2025
Sanofi EUR 100.88B 4.46B Dec/2025
Supernus Pharmaceuticals USD 3B 1.24B Sep/2025
Zoetis USD 64.85B 4.58B Sep/2025